ANCA-associated Primary Necrotizing Vasculitides

Clinical trial pipeline · Data from ClinicalTrials.gov

See which ANCA-associated Primary Necrotizing Vasculitides trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 3

NCT02117453

Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Marker…

The purpose of this study is to assess whether rosuvastatin could reduce the subclinical markers of atherosclerosis and the incidence of major cardiovascular ev…

France121 participantsStarted 2014-10-27

Treatment: Rosuvastatin, Placebo